Profile
Kenneth P.
Aron worked as the Chief Technology Officer at Abaxis, Inc. from 2000 to 2018.
Prior to that, he was the Vice President of Research, Development & Engineering at CardioGenesis Corp.
from 1996 to 1998 and the Vice President of Engineering & Technology at Incyte Pharmaceuticals, Inc. from 1998 to 1999.
Former positions of Kenneth P. Aron
Companies | Position | End |
---|---|---|
ABAXIS INC | Chief Tech/Sci/R&D Officer | 2018-07-31 |
Incyte Pharmaceuticals, Inc.
Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | 1999-10-31 |
CardioGenesis Corp.
CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Chief Tech/Sci/R&D Officer | 1998-03-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Abaxis, Inc.
Abaxis, Inc. Medical SpecialtiesHealth Technology ABAXIS, Inc. engages in the development, manufacture, and marketing of portable blood analysis systems. It operates through the following segments: Medical Market, Veterinary Market, and Other. The Medical Market segment serves a customer group consisting of physicians’ office practices across multiple specialties, urgent care, outpatient and walk-in clinics, health screening operations, home care providers, nursing homes, ambulance companies, oncology treatment clinics, dialysis centers, pharmacies, hospital laboratories, military installations, pharmaceutical clinical trials, and cruise ship lines. The Veterinary Market segment focuses on animal hospitals, animal clinics with mixed practices of small animals, birds and reptiles, equine and bovine practitioners, veterinary emergency clinics, veterinary referral hospitals, universities, government, pharmaceutical companies, biotechnology companies, and private research laboratories. The company was founded by Vladimir E. Ostoich in April 1989 and is headquartered in Union City, CA. | Health Technology |
CardioGenesis Corp.
CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Health Technology |
Incyte Pharmaceuticals, Inc.
Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA. | Health Technology |
- Stock Market
- Insiders
- Kenneth P. Aron